Results
|
|
14921.
|
|
|
|
14922.
|
|
|
|
14923.
|
Safety and efficacy of Virend for topical treatment of genital and anal herpes simplex lesions in patients with AIDS. [electronic resource] by
- Orozco-Topete, R
- Sierra-Madero, J
- Cano-Dominguez, C
- Kershenovich, J
- Ortiz-Pedroza, G
- Vazquez-Valls, E
- Garcia-Cosio, C
- Soria-Cordoba, A
- Armendariz, A M
- Teran-Toledo, X
- Romo-Garcia, J
- Fernandez, H
- Rozhon, E J
Producer: 19970925
In:
Antiviral research vol. 35
Availability: No items available.
|
|
|
14924.
|
|
|
|
14925.
|
|
|
|
14926.
|
|
|
|
14927.
|
|
|
|
14928.
|
|
|
|
14929.
|
|
|
|
14930.
|
|
|
|
14931.
|
|
|
|
14932.
|
|
|
|
14933.
|
|
|
|
14934.
|
|
|
|
14935.
|
|
|
|
14936.
|
A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge. [electronic resource] by
- Zhang, X
- Chentoufi, A A
- Dasgupta, G
- Nesburn, A B
- Wu, M
- Zhu, X
- Carpenter, D
- Wechsler, S L
- You, S
- BenMohamed, L
Producer: 20090611
In:
Mucosal immunology vol. 2
Availability: No items available.
|
|
|
14937.
|
|
|
|
14938.
|
|
|
|
14939.
|
|
|
|
14940.
|
|